首页> 美国卫生研究院文献>other >You Can Do That? Performing Total Recanalization of Completely Stented Arterial-venous Grafts
【2h】

You Can Do That? Performing Total Recanalization of Completely Stented Arterial-venous Grafts

机译:你能做到吗?进行完全覆膜的动静脉移植物的完全再通气

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Establishing venous access in chronic dialysis patients is conducted by the insertion of polytetrafluoroethylene arterial-venous (AV) grafts. The continual access of these grafts allows for potential failure over extended periods of hemodialysis treatment, as a result of thrombosis and pseudoaneurysm formation. Patency of AV grafts requires interventional management of thrombosis and pseudoaneurysm formation, including thrombectomy and covered stent placement, respectively. In 2013, the Food and Drug Administration approved the Gore REVISE study, giving indication for covered stents within AV grafts. If covered stent placement is required to treat a thrombosed AV graft, it is still possible to perform a percutaneous thrombectomy procedure afterwards. Direct access of the AV graft by passing through both the graft material and covered stents allows for interventional radiology management to be performed without compromise of the stent or graft. This interventional method of direct access can salvage the AV graft before considering further invasive management, such as a new surgical venous access site.
机译:在慢性透析患者中​​建立静脉通道是通过插入聚四氟乙烯动脉-静脉(AV)移植物进行的。由于血栓形成和假性动脉瘤的形成,这些移植物的连续进入允许在血液透析治疗的较长时期内潜在的衰竭。 AV移植的通畅性要求对血栓形成和假性动脉瘤形成进行介入治疗,分别包括血栓切除术和覆膜支架放置。 2013年,美国食品药品监督管理局(FDA)批准了戈尔(Gore)REVISE研究,为AV移植物中的覆膜支架提供了适应症。如果需要覆膜支架放置以治疗血栓形成的AV移植,则之后仍可以进行经皮血栓切除术。通过同时穿过移植物材料和覆盖的支架直接进入AV移植物,可以在不损害支架或移植物的情况下进行介入放射学管理。这种直接通路的介入方法可以在考虑进一步的侵入性处理(例如新的手术静脉通路部位)之前挽救AV移植物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号